Pharma IQ’s IP Strategies for Crystalline Forms Report

Pharma IQ News
Posted: 08/03/2011

Pharma IQ has just published the results of an industry wide IP Crystals Survey, conducted recently among 6,000 patent specialists with over 65 % of those surveyed  directly responsible for application drafting.

The results showed that that almost 85.3 per cent of firms are currently involved in fewer than four litigation cases, while only 14.3 per cent have a greater number of court proceedings to handle. It was also found that many drug companies are using external counsels.

Pharma IQ News
Posted: 08/03/2011